Targeted Nanoparticles Containing the Proresolving Peptide Ac2-26 Protect Against Advanced Atherosclerosis in Hypercholesterolemic Mice

Science Translational Medicine - United States
doi 10.1126/scitranslmed.aaa1065
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

Ticagrelor Induces Paraoxonase-1 (PON1) and Better Protects Hypercholesterolemic Mice Against Atherosclerosis Compared to Clopidogrel

PLoS ONE
Multidisciplinary
2019English

Importance of Receptor-Targeted Systems in the Battle Against Atherosclerosis

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2013English

Monotonous Diets Protect Against Acute Colitis in Mice

Journal of Pediatric Gastroenterology and Nutrition
Child HealthPediatricsPerinatologyGastroenterology
2013English

Systemic Deficiency of the MAP Kinase Activated Protein Kinase 2 Reduces Atherosclerosis in Hypercholesterolemic Mice

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2007English

Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis

Macromolecular Bioscience
PlasticsPolymersMaterials ChemistryBiomaterialsBioengineeringBiotechnology
2019English

Use of the Antimicrobial Peptide Pardaxin (GE33) to Protect Against Methicillin-Resistant Staphylococcus Aureus Infection in Mice With Skin Injuries

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

Edaravone Protect Against Retinal Damage in Streptozotocin-Induced Diabetic Mice

PLoS ONE
Multidisciplinary
2014English

Sesaminol Glucosides Protect Β-Amyloid Peptide-Induced Cognitive Deficits in Mice

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2009English

PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy